BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics
Saved in:
Published in | Haematologica (Roma) Vol. 109; no. 4; pp. 1253 - 1258 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Italy
Fondazione Ferrata Storti
01.04.2024
Ferrata Storti Foundation |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Correspondence-2 content type line 23 Disclosures Contributions RP, EH and AL designed the research. RP, JR, YW and SQ performed the research. MV and JR contributed vital reagents. RP, YW, EH, EM and AL analyzed the data. RP wrote the original draft. RP, EM, EH and AL reviewed and edited the manuscript. This work is supported by a NCI/NIH grant R35 CA242427 and a research agreement with Novartis A10838. RP and MV have no conflicts of interest to disclose. JR is a consultant for Zentalis Pharmaceuticals. SQ and EH are employees at and shareholders of Novartis. EM and YW were employees at and shareholders of Novartis during this work. AL is on the scientific advisory boards of Zentalis Pharmaceuticals and Flash Therapeutics. He has performed consulting for AbbVie and Boehringer-Ingelheim. |
---|---|
ISSN: | 0390-6078 1592-8721 1592-8721 |
DOI: | 10.3324/haematol.2023.283060 |